rs10999409 - PALD1

Magnitude 2.8 · 1 study on file

Reported associations

  • Common body mass index-associated variants confer risk of extreme obesity. - Human molecular genetics (2009) · Cotsapas C, Speliotes EK, Hatoum IJ, Greenawalt DM, Dobrin R, Lum PY, Suver C, Chudin E, Kemp D, Reitman M, Voight BF, Neale BM, Schadt EE, Hirschhorn JN, Kaplan LM, Daly MJ · PubMed 19553259

    To investigate the genetic architecture of severe obesity, we performed a genome-wide association study of 775 cases and 3197 unascertained controls at approximately 550,000 markers across the autosomal genome. We found convincing association to the previously described locus including the FTO gene. We also found evidence of association at a further six of 12 other loci previously reported to influence body mass index (BMI) in the general population and one of three associations to severe childhood and adult obesity and that cases have a higher proportion of risk-conferring alleles than controls. We found no evidence of homozygosity at any locus due to identity-by-descent associating with phenotype which would be indicative of rare, penetrant alleles, nor was there excess genome-wide homoz


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Exercise

  • regular aerobic and resistance training Moderate

    Exercise is primary modifiable intervention for weight management and metabolic health in genetic obesity risk

    150 minutes moderate aerobic activity plus 2 days resistance training weekly

Lifestyle

  • structured weight management program Moderate

    Genetic variant rs10999409 increases extreme obesity risk 1.3-fold; evidence-based weight management mitigates this risk

    Discuss enrollment with healthcare provider if BMI trending upward

Screening

  • annual weight, BMI, and metabolic parameters Moderate

    Genetic obesity risk warrants proactive metabolic surveillance to detect dysglycemia or dyslipidemia early

    Annual: weight, BMI, fasting glucose, lipid panel; discuss obesity-related comorbidities